Wells Fargo’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-10,000
Closed -$5.2M – 7262
2024
Q4
$5.2M Buy
+10,000
New +$5.5M ﹤0.01% 2411
2024
Q1
– Sell
-700
Closed -$372K – 7707
2023
Q4
$372K Hold
700
– – ﹤0.01% 4064
2023
Q3
$354K Hold
700
– – ﹤0.01% 3988
2023
Q2
$365K Sell
700
-1,100
-61% -$594K ﹤0.01% 4169
2023
Q1
$1.04M Buy
1,800
+1,200
+200% +$676K ﹤0.01% 3347
2022
Q4
$330K Buy
+600
New +$318K ﹤0.01% 3891
2022
Q1
– Sell
-1,600
Closed -$1.07M – 7809
2021
Q4
$1.07M Buy
+1,600
New +$999K ﹤0.01% 4049
2019
Q3
– Sell
-34,900
Closed -$1.03M – 6719
2019
Q2
$1.03M Buy
+34,900
New +$9.61M ﹤0.01% 3844

Other funds holding TMO

Wells Fargo's TMO Position: Q2 2026 in Review

Wells Fargo increased its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, buying an estimated $7.16M and bringing the position to 1,458,431 shares worth $731M. The position accounts for 0.12% of the portfolio, ranked #159.

Wells Fargo first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.27B in Q4 2021. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wells Fargo held 1,458,431 shares of Thermo Fisher Scientific worth $731M as of Q2 2026.
  • Wells Fargo bought 14,919 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.16M.
  • Thermo Fisher Scientific made up 0.12% of Wells Fargo's portfolio in Q2 2026, its #159 holding.
  • Wells Fargo first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Thermo Fisher Scientific position peaked at $1.27B in Q4 2021.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.